Hallandale Pharmacy

What Hallandale Pharmacy does

Hallandale Pharmacy is a privately held pharmaceutical compounding business founded in 2003 and headquartered in Fort Lauderdale, Florida, operating from a 60,000-square-foot PCAB-accredited facility. The company serves healthcare providers — physicians, medical groups, and clinics across the Southeast United States — who prescribe custom-compounded medications that are fulfilled directly to patients. Hallandale monetizes on a prescription-based model, generating revenue through the sale of compounded pharmaceuticals spanning 13 therapeutic categories: Women's Health, Men's Health, Hormone Replacement, Weight Management, Sexual Wellness, Dermatology, IV Therapy & Supplements, Peptide Therapy, Fertility, Vitality, Custom Compound, Ophthalmology, and Nausea. Its current product mix is anchored on GLP-1 receptor agonists (Semaglutide in Double-Strength 5 mg/mL and standard 2.5 mg/mL Flex-Dose vials of 2 mL, 3 mL, and 4 mL) and dual GIP/GLP-1 agonists (Tirzepatide Forte 15 mg/mL and standard 10 mg/mL Flex-Dose vials of 1 mL, 2 mL, 3 mL, and 4 mL), with custom compound services offered for non-standard prescriptions.

The go-to-market is B2B and sales-led, leveraging a provider-referral channel in which doctors, medical groups, and clinics prescribe through Hallandale's electronic prescription platform and patients receive fulfillment through the pharmacy. Provider-facing technology includes a dedicated onboarding portal at start.hallandalerx.com, a patient refill portal at partner.hallandalerx.com, and API integration for interoperability with provider healthcare systems. Supporting capabilities include clinical support services, fast prescription turnaround, and customer service positioning aimed at prescriber retention. Pricing is not publicly disclosed; medications are prescription-based and likely covered by a mix of insurance reimbursement and cash-pay compounding, particularly for the GLP-1 weight management line.

Hallandale Pharmacy is independently owned with no disclosed parent company, subsidiaries, institutional investors, or M&A activity. Ownership, revenue figures, and management team composition are not publicly disclosed in available sources, leaving financial and governance details opaque. The company is actively operating with stated business hours Monday through Friday, 9:30 AM to 6:30 PM, and maintains a public careers page indicating ongoing hiring.

Name

Hallandale Pharmacy

Legal name

Hallandale Pharmacy

Website

https://hallandalerx.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Hallandale Pharmacy is a privately held PCAB-accredited compounding pharmacy in Fort Lauderdale, Florida, serving healthcare providers across the Southeast U.S. with custom-compounded medications — anchored by GLP-1 and GIP/GLP-1 injectables — across 13 therapeutic categories from a 60,000 sq ft facility.

Ownership category

akta.pro rank

Product category

Compounding Pharmacy

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (45611), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro industry

PRIMARYHSABALAL

Compounding & Customized Medication Management Support

Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support

SECONDARYHLACAKAG

Specialty Pharmacy & Complex Therapy Management Platforms

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

SECONDARYHLACAKAH

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

• Compounding pharmacy services
• Custom pharmaceutical compounding
• Weight management medications
• Hormone replacement therapy
• Electronic prescription platform

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Compounded Medications: Revenue generated from custom compounded pharmaceuticals prescribed by healthcare providers. Medications include hormone replacement therapies, weight management drugs (Semaglutide, Tirzepatide), peptide therapies, and specialty compounds across multiple therapeutic categories.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Hallandale Pharmacy operates a PCAB-accredited compounding pharmacy that prepares custom-formulated medications prescribed by healthcare providers across 13 therapeutic categories including women's health, men's health, hormone replacement, weight management, sexual wellness, dermatology, fertility, peptide therapy, and ophthalmology. The pharmacy compounds injectable GLP-1 and dual GIP/GLP-1 receptor agonist formulations (Semaglutide and Tirzepatide in multiple vial sizes and concentrations) and supports providers through electronic prescription platforms and API integration for seamless prescribing workflows.

Product overview

Hallandale Pharmacy is a compounding pharmacy offering a diverse portfolio of specialty medications across 13 therapeutic categories including Women's Health, Men's Health, Hormone Replacement, Weight Management, Sexual Wellness, Dermatology, IV Therapy & Supplements, Peptide Therapy, Fertility, Vitality, Custom Compound, Ophthalmology, and Nausea. The core product portfolio centers on GLP-1 receptor agonists (Semaglutide in Double-Strength and standard Flex-Dose formulations in 2mL, 3mL, and 4mL vials) and dual GIP/GLP-1 agonists (Tirzepatide in Forte and standard Flex-Dose formulations in 1mL, 2mL, 3mL, and 4mL vials). The pharmacy differentiates through custom compounding capabilities (PCAB-accredited), fast turnaround times, superior customer service, and clinical support. The technology platform includes electronic prescription systems, provider and patient portals for digital prescription management.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Compounding Services
• Semaglutide Flex-Dose Injectables
• Tirzepatide Flex-Dose Injectables
• Hormone Replacement Compounds
• Women's Health Compounds
• Men's Health Compounds
• Peptide Therapy Compounds
• Fertility Compounds
• Dermatology Compounds
• Sexual Wellness Compounds
• IV Therapy & Supplements

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Henry Meds: Telehealth platform partnering with compounding pharmacies to dispense weight loss and HRT medications. Comparable product set and operates in same regulatory 503A compounding space as Hallandale.
• Ro (Roman Health): Direct-to-patient telehealth and pharmacy platform offering compounded GLP-1, HRT, and men's health treatments. Comparable in product categories (weight loss, HRT) and tech-driven patient experience, but operates D2C rather than B2B provider model.
• Hims & Hers Health: Public telehealth and pharmacy platform offering compounded GLP-1 weight loss, HRT, and wellness products. Overlaps in compounding-driven product categories and tech-enabled fulfillment but pursues D2C scale rather than B2B provider sales.

Direct peers

• Empower Pharmacy: Largest 503A compounding pharmacy in the US, also operating from a large Houston facility and serving providers nationwide across HRT, weight loss, and custom compounds. Directly comparable in compounding scale, PCAB accreditation status, and B2B provider model.
• Wells Pharmacy Network: National 503A/503B compounding pharmacy offering HRT, urology, dermatology, and weight management compounds. Directly comparable in B2B compounding services to providers and emphasis on clinical support.
• Avella Specialty Pharmacy: Specialty and compounding pharmacy serving providers and patients with complex and customized medications. Comparable in its focus on specialty injectables, provider-referral GTM, and PCAB-accredited compounding infrastructure.
• Olympia Compounding Pharmacy: PCAB-accredited compounding pharmacy specializing in HRT, peptides, and custom compounds sold through provider prescriptions. Closely comparable in therapeutic categories, provider-driven model, and quality positioning.
• US Compounding Pharmacy: Compounding pharmacy serving providers with custom HRT, weight management, and specialty compounds. Comparable as a mid-sized 503A compounder pursuing a similar B2B provider-referral model.

Others

• Surescripts: Health information network operator for electronic prescribing and benefits information. Comparable as enabling e-prescription infrastructure that Hallandale's provider portal integrates with, though Surescripts is an infrastructure layer rather than a compounder.

Broad incumbents

• Walgreens Specialty Pharmacy: National retail and specialty pharmacy chain with broad pharmacy capabilities including some compounding services. Overlaps in specialty medication dispensing to patients and providers but does not specialize in custom compounding.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/hallandalerx
• LinkedInlinkedin.com/company/hallandalepharmacy
• Instagraminstagram.com/hallandalepharmacy

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hallandale Pharmacy